SCHEMBL25579334

SCHEMBL25579334

c1ccc(-c2cccc(-c3ccc(N(c4ccc(-c5cccc6oc7ccccc7c56)cc4)c4cccc(-c5ccccc5)c4-c4ccccc4-c4ccccc4)cc3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.37
▸ PLA2G4A P47712 4/20 0.37
▸ PLA2G10 O15496 1/20 0.35
▸ ALOX5 P09917 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ CRHR1 P34998 1/20 0.31
▸ TNKS O95271 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CDC14B O60729 1/20 0.31
▸ CDC14A Q9UNH5 1/20 0.31
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579392 0.96 BACE1 (0.33) PLA2G2APLA2G4AALOX5BACE1CRHR1
SCHEMBL25579374 0.96 BACE1 (0.33) PLA2G2APLA2G4AALOX5BACE1CRHR1
SCHEMBL25579348 0.95 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10ALOX5BACE1
SCHEMBL25577674 0.95 BACE1 (0.33) PLA2G2APLA2G4APLA2G10ALOX5BACE1
SCHEMBL25577676 0.94 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALOX5BACE1
SCHEMBL25577670 0.94 MMP12 (0.35) PLA2G2APLA2G4APLA2G10ALOX5BACE1
SCHEMBL25579466 0.94 BACE1 (0.33) ALOX5BACE1CRHR1TNKSMAPT
SCHEMBL25578775 0.93 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALOX5CRHR1
SCHEMBL25579450 0.92 ANO1 (0.34) PLA2G2APLA2G4APLA2G10BACE1CRHR1
SCHEMBL24840162 0.92 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10ALOX5CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 PLA2G2A 2335/4885PLA2G4A 3210/4885PLA2G10 3221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback